Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation

January 2006
BMC Genomics;2006, Vol. 7, p181
Academic Journal
No abstract available.


Related Articles

  • Aberrant Epigenetic Silencing Is Triggered by a Transient Reduction in Gene Expression. Oyer, Jon A.; Chu, Adrian; Brar, Sukhmani; Turker, Mitchell S. // PLoS ONE;2009, Vol. 4 Issue 3, p1 

    Background: Aberrant epigenetic silencing plays a major role in cancer formation by inactivating tumor suppressor genes. While the endpoints of aberrant silencing are known, i.e., promoter region DNA methylation and altered histone modifications, the triggers of silencing are not known. We used...

  • Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia. Ramachandran, Shaliny; Ient, Jonathan; Gƶttgens, Eva-Leonne; Krieg, Adam J.; Hammond, Ester M. // Genes;Dec2015, Vol. 6 Issue 4, p935 

    In the last few decades, epigenetics has emerged as an exciting new field in development and disease, with a more recent focus towards cancer. Epigenetics has classically referred to heritable patterns of gene expression, primarily mediated through DNA methylation patterns. More recently, it has...

  • Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. Pelzel, Heather R.; Schlamp, Cassandra L.; Nickells, Robert W. // BMC Neuroscience;2010, Vol. 11, p62 

    Background: Silencing of normal gene expression occurs early in the apoptosis of neurons, well before the cell is committed to the death pathway, and has been extensively characterized in injured retinal ganglion cells. The causative mechanism of this widespread change in gene expression is...

  • Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression. Imai, Kenichi; Ochiai, Kuniyasu // Journal of Oral Science;Mar2011, Vol. 53 Issue 1, p1 

    Although approximately 200 distinct cell types -- including fibroblasts, neurons, and hematopoietic cells -- possess the same DNA sequence, they have diverse functions in humans and exhibit considerably different gene expression patterns. It has become increasingly clear that epigenetic...

  • Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells. Xu, Shaohua; Ren, Juan; Chen, Hai Bin; Wang, Yanlin; Liu, Qingyou; Zhang, Run; Jiang, Shi-Wen; Li, Jinping // Current Pharmaceutical Design;Apr2014, Vol. 20 Issue 11, p1881 

    DNA methyltransferase (DNMT) and histone deacetylase are key enzymes mediating the epigenetic regulation of gene expression. DNA hypermethylation and/or histone deacetylation in promoter regions is often associated with downregulation or silencing of transcription. Epigenetic silencing of tumor...

  • Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. Hassan, Faiz-ul; Rehman, Muhammad Saif-ur; Khan, Muhammad Sajjad; Ali, Muhammad Amjad; Javed, Aroosa; Nawaz, Ayesha; Yang, Chengjian // Frontiers in Genetics;6/4/2019, pN.PAG 

    Curcumin (a polyphenolic compound in turmeric) is famous for its potent anti-inflammatory, anti-oxidant, and anti-cancer properties, and has a great potential to act as an epigenetic modulator. The epigenetic regulatory roles of curcumin include the inhibition of DNA methyltransferases (DNMTs),...

  • Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells. Kim, Moon-Hong; Kim, Moon-Sun; Kim, Wonwoo; Kang, Mi Ae; Cacalano, Nicholas A.; Kang, Soon-Beom; Shin, Young-Joo; Jeong, Jae-Hoon // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Suppressor of cytokine signaling (SOCS) family is an important negative regulator of cytokine signaling and deregulation of SOCS has been involved in many types of cancer. All cervical cancer cell lines tested showed lower expression of SOCS1, SOCS3, and SOCS5 than normal tissue or cell lines....

  • Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells Zhang, Juyong; Chen, Yue-Lei; Ji, Guanyu; Fang, Weiying; Gao, Zhaowei; Liu, Yi; Wang, Jun; Ding, Xiaoyan; Gao, Fei // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    The epithelial to mesenchymal transition (EMT) has been well recognized for many decades as an essential early step in the progression of primary tumors towards metastases. Widespread epigenetic reprogramming of DNA and histone modifications tightly regulates gene expression and cellular...

  • Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy? Carlos Perez-Plasencia; Duenas-Gonzalez, Alfonso // Molecular Cancer;2006, Vol. 5, p1 

    Background: Transcriptome analysis shows that the chemotherapy innate resistance state of tumors is characterized by: poorly dividing tumor cells; an increased DNA repair; an increased drug efflux potential by ABC-transporters; and a dysfunctional ECM. Because chemotherapy resistance involves...

  • Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation. Yu-Wen Zhang; Staal, Ben; Dykema, Karl J.; Furge, Kyle A.; Vande Woude, George F. // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Epigenetic silencing is one of the mechanisms leading to inactivation of a tumor suppressor gene, either by DNA methylation or histone modification in a promoter regulatory region. Mitogen inducible gene 6 (MIG-6), mainly known as a negative feedback inhibitor of the epidermal growth factor...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics